Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 42

Adults with autism show similar brain mapping of body parts as typically developing adults

Autism spectrum disorder (ASD), a neurodevelopmental condition, is often associated with difficulties in social communication and repetitive behavior. Previous research reveals that people with ASD often find it challenging to interpret intentions from body language and have difficulty recognizing faces and emotions, which may contribute to their social communication problems.

Scientists speculate that these challenges might arise from differences in how the brain perceives faces and body parts, i.e., how individuals with ASD represent the human body. However, until now, no study had clearly mapped how body parts are represented in the brains of adults with autism or whether that organization differs from normal or typically developing (TD) adults.

In a detailed neuroimaging study involving adults in Japan, researchers addressed this knowledge gap by examining how ASD represents body parts in the brain. This study was published in the journal Imaging Neuroscience. A team of researchers used imaging (fMRI) to compare in adults with ASD and TD adults as they viewed images of body parts.

Cross-omics risk scores of inflammation markers are associated with all-cause mortality: The Canadian Longitudinal Study on Aging

We developed single-and multi-omics risk scores to assess blood inflammation markers and validated them across three cohorts. Our multi-omics models outperformed blood markers in predicting all-cause mortality, offering a more comprehensive approach to capturing inflammation burden. This may help identify at-risk populations for targeted interventions to reduce inflammation-related mortality.

Caltech’s New Smart Pill Can Read Your Gut Like Never Before

Researchers are gaining a deeper appreciation for the critical role the gastrointestinal (GI) tract plays in maintaining overall health. Beyond its primary responsibilities in digestion, the GI system contributes to the production of hormones, immune cells, and neurotransmitters that influence brain function and emotional well-being.

Because of this, the GI tract contains a wide array of biomarkers that are valuable for diagnosing, tracking, and managing disease—from short-chain fatty acids associated with metabolic syndrome to cytokines linked to inflammation.

However, current technologies fall short when it comes to capturing this biochemical information directly from the GI tract. Existing methods, such as fecal sampling and tissue biopsies, are often invasive, costly, and unable to deliver continuous or comprehensive real-time data throughout the length of the digestive system.

Abstract: Synaptic plasticity is obstructed by pathogenic tau in the brain

Representing a key mechanism that underlies memory loss in Alzheimer’s disease (AD) and related tauopathies. Here, we found that reduced levels of the memory-associated protein KIdney/BRAin (KIBRA) in the brain and increased KIBRA protein levels in cerebrospinal fluid are associated with cognitive impairment and pathological tau levels in disease. We next defined a mechanism for plasticity repair in vulnerable neurons using the C-terminus of the KIBRA protein (CT-KIBRA). We showed that CT-KIBRA restored plasticity and memory in transgenic mice expressing pathogenic human tau; however, CT-KIBRA did not alter tau levels or prevent tau-induced synapse loss. Instead, we found that CT-KIBRA stabilized the protein kinase Mζ (PKMζ) to maintain synaptic plasticity and memory despite tau-mediated pathogenesis. Thus, our results distinguished KIBRA both as a biomarker of synapse dysfunction and as the foundation for a synapse repair mechanism to reverse cognitive impairment in tauopathy.

1Buck Institute for Research on Aging, Novato, California, USA.

2Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.

3Gladstone Institutes, San Francisco, Califoria, USA.

4Weill Institute for Neurosciences, Department of Pathology, University of California San Francisco, San Francisco, California, USA.

MIT engineers develop electrochemical sensors for cheap, disposable diagnostics

Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to detect a variety of diseases, including cancer or infectious diseases such as influenza and HIV.

These electrochemical sensors make use of a DNA-chopping enzyme found in the CRISPR gene-editing system. When a target such as a cancerous gene is detected by the enzyme, it begins shearing DNA from the electrode nonspecifically, like a lawnmower cutting grass, altering the electrical signal produced.

One of the main limitations of this type of sensing technology is that the DNA that coats the electrode breaks down quickly, so the sensors can’t be stored for very long and their storage conditions must be tightly controlled, limiting where they can be used. In a new study, MIT researchers stabilized the DNA with a polymer coating, allowing the sensors to be stored for up to two months, even at high temperatures. After storage, the sensors were able to detect a prostate cancer gene that is often used to diagnose the disease.

CTE and normal aging are difficult to distinguish, new study finds

In recent years, some scientists and advocates have warned that playing contact sports like football and hockey may increase the risk of brain diseases like Alzheimer’s disease or chronic traumatic encephalopathy (CTE) due to a buildup of a specific protein in the brain.

But a new Northwestern Medicine study of 174 donated brains, including some from former high school and , pumps the brakes on that theory.

“The long and short of it is no, this protein in this specific brain region is not increased in people who played football at the amateur level. It throws a little bit of cold water on the current CTE narrative,” said corresponding author Dr. Rudolph Castellani, professor of pathology at Northwestern University Feinberg School of Medicine and a Northwestern Medicine neuropathologist.

Scientists create biological artificial intelligence system

Australian scientists, including at the Charles Perkins Centre, University of Sydney, have successfully developed a research system that uses ‘biological artificial intelligence’ to design and evolve molecules with new or improved functions directly in mammal cells. The researchers said this system provides a powerful new tool that will help scientists develop more specific and effective research tools or gene therapies.

Named PROTEUS (PROTein Evolution Using Selection) the system harnesses ‘directed evolution’, a lab technique that mimics the natural power of evolution. However, rather than taking years or decades, this method accelerates cycles of evolution and natural selection, allowing them to create molecules with new functions in weeks.

This could have a direct impact on finding new, more effective medicines. For example, this system can be applied to improve gene editing technology like CRISPR to improve its effectiveness.

Cutting to the core of how 3D structure shapes gene activity

In biology textbooks and beyond, the human genome and DNA therein typically are taught in only one dimension. While it can be helpful for learners to begin with the linear presentation of how stretches of DNA form genes, this oversimplification undersells the significance of the genome’s 3D structure.

To fit in the nucleus of our cells, six feet of DNA is wound up like thread on protein spools called histones. In its packaged form called chromatin, coiled up DNA features many loops and clumps. While it may look random and messy to the untrained eye, these tumbleweed-like shapes bring certain genomic regions into close contact while sheltering others.

Problems with this 3D structure are associated with many diseases including developmental disorders and cancer. Almost 12% of in have incurred issues with their , while other structural issues are known to cause T-cell acute lymphoblastic leukemia.

Antibody mapping chip speeds up vaccine research by revealing hidden binding sites quickly

A new microchip invented by Scripps Research scientists can reveal how a person’s antibodies interact with viruses—using just a drop of blood. The technology offers researchers faster, clearer insights that could help accelerate vaccine development and antibody discovery.

“This lets us take a quick snapshot of antibodies as they are evolving after a vaccine or pathogen exposure,” says Andrew Ward, professor in the Department of Integrative Structural and Computational Biology at Scripps Research and senior author of the new paper published in Nature Biomedical Engineering on June 3, 2025. “We’ve never been able to do that on this timescale or with such tiny amounts of blood before.”

When someone is infected with a virus, or receives a vaccine, their creates new antibodies to recognize the foreign invader. Some antibodies work well against the pathogen, while others attach to it only weakly. Figuring out exactly which parts of the virus the best antibodies stick to is key information for scientists trying to optimize vaccines, since they want to design vaccines that elicit strong, reliable immune responses.